These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15657201)

  • 1. Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy.
    Matos G; Steen L; Leya F
    Heart; 2005 Feb; 91(2):e11. PubMed ID: 15657201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
    Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
    Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
    Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
    Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ
    Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.
    Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A
    J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients).
    Cherradi R; Ouldzein H; Zouaoui W; Elbaz M; Puel J; Carrié D
    Arch Cardiovasc Dis; 2008 Jan; 101(1):11-7. PubMed ID: 18391867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of left main coronary artery stenosis with drug-eluting stent following heart transplantation.
    Xue YZ; Liu WT; Wang XH; Gao H; Wang LX
    Intern Med; 2012; 51(9):1037-41. PubMed ID: 22576383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
    Colombo A; Moses JW; Morice MC; Ludwig J; Holmes DR; Spanos V; Louvard Y; Desmedt B; Di Mario C; Leon MB
    Circulation; 2004 Mar; 109(10):1244-9. PubMed ID: 14981005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy.
    Cilingiroglu M; Chilakapati V; Dunlap S; Leesar MA
    Cardiovasc Revasc Med; 2010; 11(2):120-3. PubMed ID: 20347805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
    Lee MS; Tarantini G; Xhaxho J; Yang T; Ehdaie A; Bhatia R; Favaretto E; Tobis J
    JACC Cardiovasc Interv; 2010 Apr; 3(4):378-82. PubMed ID: 20398863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unprotected left main coronary artery stenting for cardiac allograft vasculopathy.
    Chan AW; Carere RG; Khatri S; Della Siega A; Ignaszewski AP; Webb JG
    J Heart Lung Transplant; 2001 Jul; 20(7):776-80. PubMed ID: 11448810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes.
    Tarantini G; Favaretto E; Gardin A; Napodano M; Isabella G; Panfili M; Gerosa G; Iliceto S; Ramondo A
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):396-402. PubMed ID: 18334895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of coronary artery stenosis. Considerable improvement of the catheter-based technique].
    Tornvall P; Jensen J; Nilsson T
    Lakartidningen; 2002 Jun; 99(25):2840-3. PubMed ID: 12143137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the left main be covered entirely with drug-eluting stents in percutaneous intervention.
    Lozano I; Avanzas P; Moris C
    J Invasive Cardiol; 2006 Nov; 18(11):E276-8. PubMed ID: 17090829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.